Page last updated: 2024-10-20

pteridines and Bone Loss, Osteoclastic

pteridines has been researched along with Bone Loss, Osteoclastic in 1 studies

Research Excerpts

ExcerptRelevanceReference
"By using a mouse model of osteosarcoma induced by paratibial injection of cells, we assessed the impact of Smad7 overexpression or SD-208 on tumor growth, tumor microenvironment, bone remodeling, and metastasis development."3.80Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma. ( Amiaud, J; Bougras, G; Chesneau, J; Heymann, D; Heymann, MF; Lamora, A; Le Deley, MC; Leduc, M; Redini, F; Stresing, V; Talbot, J; Taurelle, J; Verrecchia, F, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lamora, A1
Talbot, J1
Bougras, G1
Amiaud, J1
Leduc, M1
Chesneau, J1
Taurelle, J1
Stresing, V1
Le Deley, MC1
Heymann, MF1
Heymann, D1
Redini, F1
Verrecchia, F1

Other Studies

1 other study available for pteridines and Bone Loss, Osteoclastic

ArticleYear
Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Oct-01, Volume: 20, Issue:19

    Topics: Animals; Bone Neoplasms; Bone Resorption; Cell Line, Tumor; Disease Models, Animal; Female; Gene Exp

2014